Daniel R. Ouzts

Daniel R. Ouzts discloses dealings in Dialysis Corp of America to SEC (Form 4). We count 4 filings; the first trade dates from 27 June 2006 and the latest from 2 June 2010.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

Most recently, on 4 June 2010, the filings show a transaction worth €1.3M in Dialysis Corp of America. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.